Enmetazobactam (AAI-101) is an antibiotic adjuvant drug which acts as a beta-lactamase inhibitor, preventing the breakdown of other antibiotic drugs. Enmetazobactam was invented by a team of scientists at Orchid Pharma in India and then out-licensed to Allecra Therapeutics for further development.US patent No.7687488B2 Novel 2-substituted methyl penam derivatives, https://worldwide.espacenet.com/patent/search/family/038949982/publication/US7687488B2?q=pn%3DUS7687488 In the United States and European Union, enmetazobactam is approved for use in the combination cefepime/enmetazobactam (Exblifep). Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
References